Complaints and Suggestions
Tel: +86-755-86913119
E-mail: pro@hku-szh.org
Consulting and Services
Tel: +86-755-86913388
E-mail: imc@hku-szh.org
Address
No.1,Haiyuan 1st Road,Futian District,Shenzhen
Worktime
8:00-17:30 (Mon. - Fri.)
8:00-12:30, 14:00-17:30 (weekend,except public holidays)
2023
HK Residents Excited to Resume Dual-city Life as Border Reopens
As quarantine-free cross-border travel resumed on Sunday, the bustling flow of people between the neighboring cities of Hong Kong and Shenzhen is back, benefiting residents on both sides of the border and satisfying previously suppressed demand. On Sunday and Monday, 63,259 passengers used the three land checkpoints to travel between Shenzhen and Hong Kong, Shenzhen government data showed.Michael To Kai-tsun, a consultant doctor in the Department of Orthopaedics and Traumatology and assistant chief executive at the University of Hong Kong-Shenzhen Hospital, is very excited about the news. Before the pandemic, he commuted between the two cities, but he has had to stay longer each time in Shenzhen over the past three years. “I haven’t seen my parents for almost half a year, so I immediately went back to Hong Kong on Saturday after the announcement of the resumption of normal cross-border travel,” he said.Shenzhen-based doctor Michael To Kai-tsun takes a selfie at the Shenzhen Bay Control Point after successfully traveling to and from Hong Kong within a two-day period.He came back to work in Shenzhen on Monday morning. “The process at the checkpoint took about 10 minutes and was very smooth,” he said, adding that it took almost the same amount of time as it did before the pandemic. “I will go back to Hong Kong again for the Spring Festival holiday and then bring my family to visit friends in Shenzhen,” he said. The only thing he worries about is the quota for cross-border travel, as many people are expecting to be reunited with their family during the festival. The daily quota for people traveling in either direction between Hong Kong and the mainland is currently 60,000.Relatives are not the only ones missing him. His patients in Hong Kong, especially those with rare orthopedic diseases, have been expecting to see him. He said they were only able to communicate online before, but this time he has made appointments with some patients.The hospital is also planning more cross-border training programs and offline meetings with international professionals.“Our hospital has introduced several Hong Kong-approved medical devices in the last three years, which need experienced doctors from Hong Kong to operate them or to teach Shenzhen doctors how to operate them. It will be much more convenient for the professional exchange with the reopening of the border,” he said. Written by Chai HuaSource: China Daily.2022
Professor Kenneth M.C. Cheung Takes the Helm as New HCE of HKU-Shenzhen Hospital
On 19 August, 2022, the University of Hong Kong-Shenzhen Hospital (HKU-SZH) officially announced that Prof. Kenneth M.C. Cheung took the helm as Hospital-Chief-Executive of the Hospital. Ms. Hongyan Wu, Director of Shenzhen Municipal Health Commission, Prof. Xiang Zhang, President and Vice-Chancellor of The University of Hong Kong (online) and Prof. Chak-sing Lau, Dean of the Li Ka Shing Faculty of Medicine, The University of Hong Kong (online) attended the appointment ceremony.Kenneth M.C. Cheung is the Jessie Ho Professor in Spine Surgery and Chair Professor at the Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKU). He was the Head of the Department of Orthopedics and Traumatology until December 2021. He is also the Director of the Orthopedic Center at HKU-Shenzhen Hospital and leads the area of excellence program in spinal deformities.Prof. Cheung is a world-renowned academic spine surgeon with special expertise in the treatment of spinal deformities in children and adults. He is the former President of the Hong Kong College of Orthopedic Surgeons, and he was the first Chinese President of the international Scoliosis Research Society (SRS), the world's highest academic institution of spinal surgery (2016-2017). He not only led the development of orthopedics in Hong Kong, but also played a significant role on the international stage on behalf of China's orthopedics. In 2021, he was awarded the prestigious Walter P. Blount Humanitarian Award by the Scoliosis Research Society for his outstanding service to those with spinal deformity, and for generosity to the profession and society.Prof. Kenneth M.C. Cheung at SRS 51st Annual Meeting & CourseProf. Cheung is a valid candidate of Academician of Chinese Academy of Engineering. Since 1987, Prof. Cheung has been working in the front line of orthopedic clinical services, teaching and research. His clinical and translational research in the prevention and treatment of scoliosis has reached international level. He has been invited to give lectures at many international academic events and has extensive experience in science and medicine related matters. He has received 37 awards for research excellence, published 380 SCI articles in international journals such as Lancet, 23 book chapters and holds 65 patents. He also serves as the Editor-in-Chief of the Journal of Orthopedic Surgery. 2022 marks the 25th anniversary of Hong Kong's return to the motherland, and the 10th anniversary of HKU-SZH's founding. Over the past decade, the Hospital has been actively pioneering in innovating the management system, operation mechanism and clinical service model of public hospitals, as well as promoting the concept of green healthcare, introducing cutting-edge medical technology, and advancing the cross-border medical services between Hong Kong and Shenzhen. The Hospital has become one of the high-level hospitals in Guangdong Province and one of the pilot hospitals for the high-quality development of national public hospitals.Prof. Cheung addresses his grateful thanks to the supports to the Hospital from governments and patients. He indicates that the success of the HKU-SZH is result of the joint efforts of all staff of the Hospital. Under the strong leadership of former Hospital-Chief-Executives, Prof. Grace Tang and Prof. Chung-Mau Lo, the Hospital has laid a good foundation and achieved wide recognition from public with its excellence in clinical services, teaching, research and management. He will continue to work with all staff to strive for the target of building a high-quality development model for public hospitals.Regarding the future development of the Hospital, Prof. Cheung said, "As doctors, we should treat patients with empathy, which is essential to improving the quality of clinical services. I hope that we will make HKU-SZH a modern hospital that meets patients' needs and brings happiness to our staff. We should be open-minded and encourage staff members to make innovative and groundbreaking explorations in clinical healthcare and scientific research."The President and Vice-Chancellor of HKU Prof. Xiang Zhang welcomes Prof. Cheung to the new position. He said, "Given Prof. Cheung's outstanding academic credentials, administrative experiences and international exposure, we are confident that he will bring excellent leadership to the Hospital, extending our presence in the Greater Bay Area."Director of Shenzhen Municipal Health Commission Ms. Hongyan Wu expressed her expectation that Prof. Cheung could lead the Hospital in making greater contributions to cross-border healthcare services in the GBA region by leveraging policy supports and the Hospital's strengths. .2022
Concert Held to Celebrate HK’s Return, Hospital Anniversary
A special concert presented by Shenzhen and Hong Kong medical workers, local residents and a professional orchestra was staged at the atrium of the Outpatient and Medical Services Block in the University of Hong Kong-Shenzhen Hospital (HKU-SZH) yesterday.Hospital staff and guest performers pose for a group photo at the concert at the atrium of the Outpatient and Medical Services Block in the University of Hong Kong-Shenzhen Hospital (HKU-SZH) yesterday. (Photo by HKUSZH)Themed “Home Coming,” the concert was held to commemorate the 25th anniversary of Hong Kong’s return to the motherland as well as the 10th anniversary of the hospital’s establishment.Joe Fan (L in the front), assistant chief executive of the HKU-SZH, plays the bass while Liu Zhihai (R), a thoracic surgeon, plays the guitar at a concert staged in the atrium of the hospital’s Outpatient and Medical Services Block yesterday. (Photo by Zhang Yu)The concert began with a dance performed by the hospital’s 10-member dance team featuring clinical nurses, and was followed by four songs by a chorus, a song performed by a group of children, a piano quintet performed by an orchestra, and ended with a band performance by hospital employees.Irene Chan Sau-vai (R), manager of the HKU-SZH’s hematopoietic stem cell transplant laboratory, plays the piano for her song “Home Coming” while Wong Ching-gnor, the hospital's CFO, plays the harmonica at the concert yesterday. (Photo by HKUSZH)“July 1, 1997 was the most important day in Hong Kong’s history, a day when the Chinese nation joined in jubilation. July 1, 2022 will be the 25th anniversary of Hong Kong’s return to the motherland, and the 10th anniversary of HKU-SZH’s founding,” Lo Chung-mau, chief executive of HKU-SZH, said via video link.Musicians with Shenzhen Metropolis Orchestra perform at the concert. (Photo by HKUSZH)“We sincerely wish Hong Kong a better tomorrow and the motherland a more prosperous and stronger future. We also sincerely hope that the hospital will become a benchmark among national hospitals that pursue high-quality development,” Lo added.Audience at the concert. (Photo by HKUSZH)Lo also expressed gratitude to governments at all levels and all sectors of society for their strong support for the hospital’s development, as well as citizens and the media for their trust in the hospital over the past decade.“Home Coming,” an original song created by Irene Chan Sau-vai, manager of the hospital’s hematopoietic stem cell transplant laboratory, was a highlight at the concert.Representatives of children born in the hospital sing a song at the concert. (Photo by HKUSZH)The song, featuring a pleasant melody played by the piano, harmonica, violin and guitar, and lyrics with deep implications, was rendered by a chorus formed by the hospital’s staffers, many of whom are from Hong Kong.According to Chan, she wrote the song when she was in quarantine after returning from the U.S. in May 2021. Chan was born in Macao, grew up in Hong Kong, and later moved to the U.S. She began working for HKU-SZH in 2015 after an invitation.“I’m overjoyed to see that the song is well received at the concert, which is special and meaningful to celebrate the 25th anniversary of Hong Kong’s return and the 10th anniversary of the hospital’s founding,” Chan said.Written by Zhang YuSource: Shenzhen Daily.2022
Hundreds Benefit from Imported Drugs, Medical Devices
More than 700 patients have benefited from the “Hong Kong and Macao Medicine and Equipment Connect” policy at the University of Hong Kong-Shenzhen Hospital (HKU-SZH), according to the hospital, which was designated as the first hospital in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) to pilot the policy last year.In its latest move, the hospital has introduced absorbable antibacterial envelope — a new medical instrument for cardiac implantable electronic devices (CIEDs) — through the policy, and recently completed the first implantation case on the mainland, the hospital said yesterday.An image of a cardiac implantable electronic device.The absorbable surgical mesh envelope, which contains two antibiotics, can effectively reduce the risk of infection and complications in patients with cardiovascular diseases when electronic devices such as implantable cardioverter defibrillators and pacemakers are implanted into the body.A computer-generated image of how a CIED is used clinically.The envelope will slowly release antibiotics within seven days and be completely absorbed by the human body within nine weeks, according to the hospital.Two patients from Hong Kong, one in his 50s and the other in his 70s, have become the beneficiaries since the introduction of the envelope to the hospital.“The two patients both faced high infection risks of implantable devices, and the surgeries were very successful,” said Yiu Kai-hang, a cardiologist with HKU-SZH. “The clinical use of the envelope was the first in the GBA as well as on the Chinese mainland.”According to Yiu, a global study of over 7,000 patients who have used the absorbable antibacterial envelope has found that the envelope can reduce the incidence of major infections of CIEDs by 40% and pocket infections by 61%.As of yesterday, the two patients had been discharged from the hospital, and a third patient in need of the envelope had started surgical treatment.HKU-SZH had introduced 13 types of imported drugs that are urgently needed for clinical use and nine types of imported medical devices as of May 30.In another development, the institutional reform and community-level division of Shenzhen Municipal Health Commission was among the 19 government agencies or units in Shenzhen that were commended for their contributions to the city in piloting comprehensive reforms.The commission was recognized for such practices as improving cross-border medical services, relaxing the access of international new drugs, and promoting the agglomeration and development of Hong Kong and Macao medical institutions in Shenzhen.Official data showed Shenzhen currently has 11 Hong Kong-funded or Shenzhen-Hong Kong medical institutions. Six Hong Kong-funded medical institutions were approved to be established in the city last year.Written by Zhang YuSource: Shenzhen Daily.2022
HKU-Shenzhen Hospital 10th Anniversary Celebrations
The University of Hong Kong-Shenzhen Hospital’s celebrations for its 10th anniversary mark a milestone of the flagship of healthcare reform in China. The celebration highlights include a launch of the Hospital’s 10th anniversary logo, a proposed flag hoisting ceremony and philanthropy concert in end-June, year-long academic symposiums, visual productions and commemorative albums, captioned press conferences and open days for communities, etc.1.HKU-SZH 10th Anniversary LogoSlogan: Innovation for Better Care (高起点 高水平 高质量)Officially launched in January 2022, the HKU-Shenzhen Hospital 10th anniversary logo was selected from a campaign open to public.The Arabic numeral "1" on the left is in shape of a flying eagle, symbolizing the cohesion of people in the Hospital practicing the values of "excellence, innovation, trust and care".The Arabic numeral "0" on the right, composed of the Hospital’s traditional logo and silk ribbons, forms the letter “S” symbolizing the city of Shenzhen, conveying the integration of Shenzhen and Hong Kong.2.HKU-SZH Press Conference on cross-border medical servicesHKU-SZH hosted a captioned press conference on healthcare services provision to cross-border citizens on 15 April 2022, right after the HKSAR announced the extension of the Hong Kong Hospital Authority Special Support Scheme for Chronic Disease Patients in Guangdong to 9 November 2022 so as to enable Hong Kong patients who have been stranded in Mainland China to seek follow-up consultation during the COVID-19 pandemic. As of March 2022, HKU-SZH had received more than 35,600 Hong Kong patients under the Special Support Scheme.As a pilot medical institution for the instruction of drugs and medical devices in urgent clinical use that have been listed in Hong Kong and Macao but not in the Mainland China, HKU-SZH has successfully imported thirteen urgently needed drugs and four medical devices as of March 2022 under the Hong Kong and Macao Medicine and Equipment Connect, benefiting more than 450 people..2022
Program for Imported Drugs Benefits Patients
More than 450 patients have benefited from the “Hong Kong and Macao Medicine and Equipment Connect” policy at the University of Hong Kong-Shenzhen Hospital (HKU-SZH), which has introduced 13 types of imported drugs that are urgently needed for clinical use and four types of imported medical devices, the hospital said Friday.HKU-SZH was designated as the first hospital to pilot the policy, as per a work plan issued by the National Medical Products Administration in November 2020. Last August, the policy was later expanded and implemented in cities across the Guangdong-Hong Kong-Macao Greater Bay Area.Photo by HKUSZHAs of March 2022, HKU-SZH had introduced medications such as Rho(D) immune globulin, alpelisib film-coated tablets and budesonide, as well as medical equipment including MAGEC growing rods, Spot Ex endoscopic tattoo, cell sorting and processing system and TYRXTM absorbable antibacterial envelope, according to the hospital.These medications and medical equipment are used in obstetrics, hematology, oncology and orthopedics.According to HKU-SZH, the medical policy benefits not only mainland residents, but also cross-border patients.Since the end of 2021, two Hong Kong children who were unable to return to Hong Kong for treatment due to the COVID-19 pandemic have successfully completed their medical treatment using the MAGEC growing rods introduced by HKU-SZH.Separately, the hospital said Friday that the special support scheme for Hong Kong’s Hospital Authority (HA) for chronic disease patients residing in Guangdong Province will continue until Nov. 9, 2022.An additional 1,000-yuan (US$157) subsidy will be granted to each patient, enabling these patients to continue receiving subsidized medical consultation at HKU-SZH during the COVID pandemic.The Hong Kong Special Administrative Region (SAR) Government launched the special support scheme on Nov. 10, 2020, and commissioned HKU-SZH to provide subsidized follow-up consultations for patients with scheduled appointments at designated specialist outpatient clinics or general outpatient clinics under the HA.As of March 31, HKU-SZH had scheduled about 42,700 medical appointments for eligible patients. Among them, about 35,600 had received medical consultations, according to the hospital.In order to facilitate Hong Kong residents who have a long stay in the mainland to see doctors, the Hong Kong SAR Government also launched the Elderly Health Care Voucher Scheme in October 2015, and designated HKU-SZH as the only pilot hospital for the use of the vouchers.According to HKU-SZH, over 46,000 medical consultations have been made so far by eligible Hong Kong elders under the scheme.Written by Zhang Yu, Chen HuanqingSource: Shenzhen Daily.2022
Genetically Engineered Stem Cells Help to Enhance Bone Regeneration
Mesenchymal stem cell-derived exosomes (MSC-Exo) have attracted much attention for their "cell-free" therapies.It provides a promising strategy for skeletal tissue regeneration. However, the regeneration capacities of exosomes are susceptible to MSC sources, as well as cell status, and further improvements are usually required.Recently, a research team led by Dr. ZHAO Xiaoli from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS), along with collaborators from the University of Hong Kong-Shenzhen Hospital, has developed a strategy of genetically engineered stem cells by bone morphogenetic protein-2 (BMP2) gene to produce exosomes (MSC-BMP2-Exo) with enhanced bone regeneration potency.The study was published in the Journal of Nanobiotechnology on March 15.Exosomes are nano-sized vesicles secreted by living cells containing proteins, RNAs and metabolites. As a natural means for cellular communication, exosomes can transport their contents to recipient cells to regulate their functions and behaviors. Stem cell derived exosomes have been found an important mediator for regulation of tissue regeneration.In this study, the researchers adapted a stem cell-mediated gene therapy (MSC-GT) strategy and applied it in bone regeneration. BMP2-modified MSCs function as cellular factories. These factories effectively produce exosomes with designed and enhanced therapeutic effects.In vitro and in vivo studies through activating BMP2/Smad signaling pathway proved that the enhanced bone regeneration function was attributed to the synergistic effect of the content derived from MSCs and the up-regulated BMP2 gene expression."The safety of drug delivery vehicles is important, and exosomes produced by these MSCs exhibited excellent biocompatibility," said Dr. ZHAO, "in addition, plasmid DNAs only induce temporary gene expression modulation, which avoids the risks of insertional mutation."By DNA tracking, a proportion of plasmid DNAs were re-encapsulated by mediator MSCs and delivered to the recipient cells through exosomes.Exosomes derived from BMP2-engineered MSCs promote bone regeneration. (Image by SIAT) Written by ZHANG Xiaomin (Shenzhen Institute of Advanced Technology)Source: Chinese Academy of Sciences.2021
SZ-HK Medical Collaboration ‘Enters New Era’
The collaboration between Shenzhen and Hong Kong in the medical field is entering a new era, said Leung Chun-ying, vice chairman of the National Committee of the Chinese People’s Political Consultative Conference, at the Second Distinguished Lecture of the University of Hong Kong-Shenzhen Hospital (HKU-SZH) held in Shenzhen on Friday.The homogeneity and integration of medical services in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) represents the general trend, said Leung, former chief executive of the Hong Kong Special Administrative Region (SAR), in a keynote speech.“Shenzhen has always been a good neighbor, brother and partner of Hong Kong,” Leung said, adding that Hong Kong cannot do without Shenzhen in being more proactive integrating into national development, while Hong Kong can be Shenzhen’s “super liaison” in promoting international exchanges.Leung Chun-ying, vice chairman of the National Committee of the Chinese People’s Political Consultative Conference, delivers a keynote speech at the 2nd Distinguished Lecture of the University of Hong Kong-Shenzhen Hospital (HKU-SZH) held in Shenzhen on Friday. “In the new era, Shenzhen and Hong Kong can fully interact and draw lessons from each other. Hong Kong and Shenzhen are like two metals, which can be forged into a new alloy to serve the whole country and the world,” he stated.According to Leung, Shenzhen and Hong Kong should have a mechanism to promote efficient interaction in the medical field. Meanwhile, the two cities should have an efficient north-south interaction in terms of talents, logistics, capital and information flows.Leung believed that the establishment of HKU-SZH was an important breakthrough in public medical services and the mainland’s medical system reform, and the hospital has gained invaluable experience in various medical reforms over the past decade.Medical cooperation in the GBA continued to deepen in recent years, as evidenced by a medical connect that allows medicines already available on the Hong Kong and Macao markets to be used in Shenzhen, as well as the awarding of the senior professional title to Hong Kong doctors in Shenzhen.Moreover, medical procedures for patients from Hong Kong and Macao seeking treatment in Shenzhen have been simplified, and medical records and payment systems between Shenzhen and Hong Kong have been linked.In October 2015, HKU-SZH became the only hospital on the mainland for Hong Kong’s elderly health care voucher scheme, benefiting Hong Kong’s senior citizens and breaking down the settlement barrier between Shenzhen and Hong Kong.In November 2020, the Hong Kong SAR Government and HKU-SZH jointly launched a special support scheme to provide subsidized follow-up consultations for Hong Kong chronic disease patients living in Guangdong Province, allowing medical records from Shenzhen and Hong Kong to be linked.Written by Zhang YuSource: Shenzhen Daily.
WeChat official account
Smart Hospital
© 2014 HKU-SZH copyright
备案号
粤ICP备13014042号-1
Search
